SCHEMBL6422012

SCHEMBL6422012

COc1cnc(-c2cncc(O)n2)c2[nH]cc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3C)c12

nearest known ligand 0.61

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 5/20 0.61
CYP2C9 P11712 5/20 0.56
CYP2C19 P33261 6/20 0.53
CYP3A4 P08684 3/20 0.53
CYP1A2 P05177 1/20 0.50
CYP2C8 P10632 1/20 0.50
CYP2B6 P20813 1/20 0.50
KCNH2 Q12809 1/20 0.50
GHSR Q92847 9/20 0.39
CFTR P13569 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1763334 1.00 CYP2D6 (0.61) CYP2D6CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL12198959 0.93 CYP2D6 (0.61) CYP2D6CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL1763048 0.93 CYP2D6 (0.63) CYP2D6CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL1763499 0.90 CYP2D6 (0.63) CYP2D6CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL2629073 0.89 CYP2C9 (0.70) CYP2D6CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL4074587 0.89 CYP2D6 (0.58) CYP2D6CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL1763359 0.89 CYP2D6 (0.58) CYP2D6CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL1763196 0.88 CYP2D6 (0.63) CYP2D6CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL1763782 0.87 CYP2D6 (0.64) CYP2D6CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL4072420 0.87 CYP2D6 (0.64) CYP2D6CYP2C9CYP2C19CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1549313-A1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES Bristol-Myers Squibb Company (US) 2005-07-06 EP disclosed
WO-2004014380-A1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2004-02-19 WO disclosed